# A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants

> **NCT05159128** · PHASE1 · WITHDRAWN · sponsor: **Janssen Pharmaceutical K.K.**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-75105186
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05159128
- **Lead sponsor:** Janssen Pharmaceutical K.K.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-11-15
- **Primary completion:** 2022-04-02
- **Final completion:** 2022-04-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05159128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05159128, "A Study of JNJ-75105186 in Healthy Japanese and Chinese Participants". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05159128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*